Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
Símbolo de cotizaciónHNGE
Nombre de la empresaHinge Health Inc
Fecha de salida a bolsaMay 22, 2025
Fundada en2016
Director ejecutivoMr. Daniel (Dan) Perez
Número de empleados1514
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 22
Dirección455 Market Street
CiudadSAN FRANCISCO
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal94105
Teléfono14156898429
Sitio Webhttps://en-gb.hingehealth.com/
Símbolo de cotizaciónHNGE
Fecha de salida a bolsaMay 22, 2025
Fundada en2016
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos